ezlopitant has been researched along with dansyl chloride in 1 studies
| Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (dansyl chloride) | Trials (dansyl chloride) | Recent Studies (post-2010) (dansyl chloride) |
|---|---|---|---|---|---|
| 22 | 2 | 1 | 283 | 4 | 86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khojasteh-Bakht, SC; O'Donnell, J; Prakash, C | 1 |
1 trial(s) available for ezlopitant and dansyl chloride
| Article | Year |
|---|---|
Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
Topics: Administration, Oral; Adult; Analytic Sample Preparation Methods; Antiemetics; Benzylamines; Biological Availability; Biotransformation; Bridged Bicyclo Compounds, Heterocyclic; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dansyl Compounds; Dealkylation; Feces; Humans; Hydroxylation; Male; Molecular Structure; Neurokinin-1 Receptor Antagonists; Oxidation-Reduction; Reference Values; Tandem Mass Spectrometry | 2007 |